BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 9368685)

  • 1. Insulin antibodies and hypoglycemia in diabetic patients. Can a quantitative analysis of antibody binding predict the risk of hypoglycemia?
    Kim MR; Sheeler LR; Mansharamani N; Haug MT; Faiman C; Gupta MK
    Endocrine; 1997 Jun; 6(3):285-91. PubMed ID: 9368685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoglycemia due to serum-complexed insulin in a patient with diabetes mellitus.
    Albert SG; Popp DA
    Diabetes Care; 1984; 7(3):285-90. PubMed ID: 6428841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged fasting hypoglycemia due to insulin antibodies in patient with non-insulin-dependent diabetes mellitus: effect of insulin withdrawal on insulin-antibody-binding kinetics.
    Van Haeften TW; Krom BA; Gerich JE
    Diabetes Care; 1987; 10(2):160-3. PubMed ID: 3582076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin glulisine may ameliorate nocturnal hypoglycemia related to insulin antibody--a case report.
    Itoh A; Saisho Y; Mitsuishi M; Oikawa Y; Kawai T; Tanaka M; Shimada A; Itoh H
    Diabetes Res Clin Pract; 2011 Nov; 94(2):e53-4; discussion e55. PubMed ID: 21724289
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunologic effects of insulin lispro [Lys (B28), Pro (B29) human insulin] in IDDM and NIDDM patients previously treated with insulin.
    Fineberg NS; Fineberg SE; Anderson JH; Birkett MA; Gibson RG; Hufferd S
    Diabetes; 1996 Dec; 45(12):1750-4. PubMed ID: 8922361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoglycemia and hyperglycemia due to insulin antibodies against therapeutic human insulin: treatment with double filtration plasmapheresis and prednisolone.
    Koyama R; Nakanishi K; Kato M; Yamashita S; Kuwahara H; Katori H
    Am J Med Sci; 2005 May; 329(5):259-64. PubMed ID: 15894868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Circulating immune complexes and insulin-binding capacity of the serum of diabetics].
    Vel'bri SK; Lilleorg AL; Kerge IaKh
    Probl Endokrinol (Mosk); 1986; 32(2):25-8. PubMed ID: 3520540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous digoxin-like immunoactivity in subjects with diabetes mellitus and hypertension.
    Martinka E; Ocenásová A; Kamenistiaková L; Dobrota D; Kerný J; Mokán M
    Am J Hypertens; 1998 Jun; 11(6 Pt 1):667-76. PubMed ID: 9657625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No relationship between insulin antibodies and hypoglycemia in insulin-treated diabetic patients.
    Ionescu-Tîrgovişte C; Mirodon Z; Paterache E; Cheţa D; Mincu I
    Rom J Intern Med; 1991; 29(3-4):189-98. PubMed ID: 1784948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequent reoccurrence of hypoglycemia in a type 2 diabetic patient with insulin antibodies.
    Zhao TY; Li F; Xiong ZY
    Mol Diagn Ther; 2010 Aug; 14(4):237-41. PubMed ID: 20799766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmune hypoglycemia in a type 2 diabetic patient with anti-insulin and insulin receptor antibodies.
    Sahin M; Tutuncu N; Guvener ND
    Diabetes Care; 2004 May; 27(5):1246-7; author reply 1247. PubMed ID: 15111569
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hypoglycemia and transient diabetes mellitus in an insulin autoimmune syndrome].
    Reisch N; Zwermann O; Reincke M
    Dtsch Med Wochenschr; 2004 May; 129(20):1135-8. PubMed ID: 15143456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case of autoimmune hypoglycemia complicated with diabetic ketoacidosis.
    Shim MS; Kim MY; Kim MJ; Lee Y; Lee BJ; Chung CH; Shin YG
    Yonsei Med J; 2004 Feb; 45(1):140-4. PubMed ID: 15004881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of immunogenicity of LY2963016 insulin glargine compared with Lantus® insulin glargine in patients with type 1 or type 2 diabetes mellitus.
    Ilag LL; Deeg MA; Costigan T; Hollander P; Blevins TC; Edelman SV; Konrad RJ; Ortmann RA; Pollom RK; Huster WJ; Zielonka JS; Prince MJ
    Diabetes Obes Metab; 2016 Feb; 18(2):159-68. PubMed ID: 26434665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of circulating insulin and proinsulin-binding antibodies in autoimmune hypoglycemia.
    Goldman J; Baldwin D; Rubenstein AH; Klink DD; Blackard WG; Fisher LK; Roe TF; Schnure JJ
    J Clin Invest; 1979 May; 63(5):1050-9. PubMed ID: 447827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Severe hypoglycemia and insulin antibodies levels in children and adolescents with type 1 diabetes].
    Mianowska B; Perenc M; Heinrich A; Bodalski J
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2003; 9(1):29-34. PubMed ID: 12831635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin kinetics in type I diabetic patients treated by continuous intraperitoneal insulin infusion: influence of anti-insulin antibodies.
    Lassmann-Vague V; Belicar P; Alessis C; Raccah D; Vialettes B; Vague P
    Diabet Med; 1996 Dec; 13(12):1051-5. PubMed ID: 8973887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin antibodies in non-insulin-dependent diabetes mellitus: effect of treatment with semisynthetic human insulin.
    Lauritano AA; Clements RS; Bell D
    Clin Ther; 1989; 11(2):268-77. PubMed ID: 2660998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin receptor antibodies in diabetes mellitus.
    Batarseh H; Thompson RA; Odugbesan O; Barnett AH
    Clin Exp Immunol; 1988 Jan; 71(1):85-90. PubMed ID: 3280181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum antibody-bound insulin as a measure of insulin antibodies in diabetic children.
    Koskinen P; Kaihola HL; Mäkelä AL; Irjala K; Knip M; Akerblom HK
    Diabetes Res; 1987 Sep; 6(1):15-9. PubMed ID: 3319351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.